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Abstract
The WHO recommends antiretroviral therapy (ART) initi-
ation immediately after HIV diagnosis. When HIV services are 
fragmented and poorly coordinated, initiation of ART can be 
delayed. MEASURE Evaluation conducted an organizational 
network intervention in Addis Ababa, Ethiopia, which increased 
referral network density and client satisfaction in the interven-
tion versus control networks. The objective of our study was 
to extend the parent study by assessing effects of network 
density on the speed of ART initiation and adherence to ART. 
Measures of client-time since HIV diagnosis, use of ART, satis-
faction with HIV-related services, and adherence were obtained 
from cross-sectional interviews with female service recipients 
with HIV/AIDS at baseline (T1, 402) and at 18-month follow-up 
(T2, 524) and compared between network sites. We used 
weighted least squares estimation with probit regression 
techniques in a structural equation modeling framework for 
analyses. On average at follow-up, clients in the intervention 
network were more likely to have quicker ART initiation, and 
were initiated on ART 15 days faster than clients in the control 
network. Moreover, quicker ART initiation was associated with 
higher adherence. A unit increase in speed of ART initiation was 
associated with 0.5 points increase in latent adherence score in 
the intervention group (p < .05). Satisfaction with care positively 
predicted adherence to ART. Network density had no direct 
effect on ART adherence. This quasi-experiment demonstrated 
that increased referral network density, through improved HIV 
client referrals, can enhance speed of ART initiation, resulting in 
improved adherence.
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INTRODUCTION
The WHO estimates the adult HIV prevalence rate 
in Ethiopia at 2.4%, and that of the urban popu-
lation at 7.7% [1]. Antiretroviral therapy (ART) 
is free-of-charge at public providers in Ethiopia 
through government and donor support, but only 
60% of HIV-positive adults are receiving ART. In 
one study, only 70% of those who started ART were 
still on treatment, highlighting retention challenges 
including client-loss to follow-up and non-adher-
ence to ART regimens [2]. Lack of access to ART 
compromises adherence, attenuates the optimum 
clinical benefit of ART, and is associated with poor 
health outcomes and increased healthcare costs [3]. 
Adherence is critical to viral suppression and has 
been shown to positively influence quality of life 
among HIV/AIDS patients [4–8].
The UNAIDS has set forth the 90-90-90 HIV 
treatment target in the hopes that all countries will 
reach the cascade of goals: (i) diagnose 90% of HIV-
infected people; (ii) initiate and retain 90% of those 
diagnosed on ART; and (iii) reduce new infections 
and AIDS-related deaths among those on ART by 
90% from 2010 to 2030 [9, 10]. Initiation and reten-
tion in, and adherence to, ART are critical for the 
Implications
Practice: The network strengthening interven-
tion assessed in this study was non-complex, 
rapid, inexpensive, and easily replicable in 
low-income settings. It utilized local and existing 
resources within the network to increase access to 
and speed of ART initiation. Interventionists can 
adopt this strategy to increase access to and speed 
of ART initiation in similar settings.
Policy: Governments and local organizations in 
low-resource settings with competing budgetary 
needs, that often can only facilitate provision of 
some but not all services HIV/AIDS clients need, 
should direct their efforts in working together 
with non-governmental actors and providers to 
increase the pool of services in catchment areas 
through client referrals, joint programming, and 
information and expertise exchange and sharing.
Research: Further research is needed to ex-
plore cost-effective, rapid, and feasible inter-
ventions that can significantly improve relevant 
socio-economic, therapy, patient- and condi-
tion-related factors to increase adherence to anti-
retroviral therapy. Future studies should also 
explore use of behavioral measures of ART ad-
herence. This study provides a framework for the 
assessment of the effect of organizational network 
strengthening interventions on speed of ART ini-
tiation and adherence.
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achievement of the goals of initiating, retaining, and 
reducing new infections. 
HIV/AIDS clients need a variety of services, 
including ART, treatment for opportunistic infec-
tions, counseling, and nutritional services to support 
their treatment, among others [11]. Despite the re-
cently adopted “Test and Start” policy, which rec-
ommends ART initiation immediately after a HIV 
diagnosis, many clients lack access to services due 
to uncoordinated, fragmented and siloed care, in-
consistent drug supplies, drug rationing, distrust of 
treatment, and lack of HIV service points [12, 13]. In 
addition, fragmented and poorly coordinated health 
services increase healthcare costs and compromise 
access and quality of care [14]. 
Health facilities and home-based care provid-
ers, hereinafter referred to as service providers, 
constitute an organizational referral network 
when they refer clients for services that they them-
selves do not provide, as often occurs in low-re-
source settings, including Addis Ababa, Ethiopia. 
The strength of the network is dependent upon 
the level and type of interaction and coordin-
ation among service providers. Higher levels of 
inter-provider interaction, also referred to as high 
referral network density (actual referral ties as a 
proportion of total potential ties between provid-
ers, measured on a scale of 0–1), has been shown 
to improve satisfaction with HIV/AIDS care and 
family planning services by increasing the pool 
of services in the network [15, 16]. Other stud-
ies have also found positive associations between 
high-density networks and access to mental and 
other health services [17–23]. 
Recognizing the potential contribution of organ-
izational networks to health outcomes, the USAID 
supported a quasi-experimental study conducted 
by MEASURE Evaluation to test the effect of a 
referral network strengthening intervention on co-
ordination and integration of HIV care and family 
planning interventions in two non-contiguous 
HIV treatment referral networks in Addis Ababa, 
Ethiopia [15, 16]. The study followed the treat-
ment and referral experiences of 926 HIV-positive 
women 18–49  years of age who were receiving 
ART and other healthcare services from pro-
vider agencies in the intervention or control sites. 
Details of the network study have been reported in 
Appendix 1 and elsewhere [15, 16]. The interven-
tion was associated with a 55% increase in network 
ties (i.e., network density) among 25 service pro-
viders (i.e., network nodes), compared with a 60% 
decrease in network density among the 26 nodes in 
the control network [15, 16]
This study builds upon the MEASURE Evaluation 
investigation. The objective was to evaluate the 
effects of the observed increase in network ties 
in Kirkos on speed of ART initiation and ART 
adherence. 
We hypothesized that (Fig. 1):
1. Increased network density in the intervention net-
work has a direct effect on speed of ART initiation
and increases the likelihood of quicker ART initiation
among HIV-positive clients;
2. Quicker speed of ART initiation increases observed
adherence to ART among clients; and
3. Increased network density in the intervention net-
work has a direct and positive effect on (increases)
adherence to ART among HIV-positive clients in that
network.
METHODS
Client interviews
The MEASURE Evaluation team enrolled clients, 
using random selection, from one large home-based 
care service provider that operated in both sites. 
Women were interviewed in two cross-sections, one 
(T1) prior to and the other (T2) 18 months follow-
ing the network intervention. At T1, 402 clients 
were interviewed: 210 at the intervention site and 
192 from the control site; at T2, 524 clients were 
interviewed: 268 from the intervention site and 256 
from the control site. At both times, clients were 
asked about personal and household-level demo-
graphic characteristics, HIV care services needed 
and received, HIV treatment status, satisfaction with 
care, and medication adherence. Although some cli-
ents may have been interviewed at both T1 and T2, 
participation in T2 interviews was not conditional 
on T1. There was no way to know whether a partici-
pant in T2 also participated in T1, because at both 
times clients were randomly sampled from agency 
caseload lists. Consequently, the samples were es-
sentially independent of each other.
Fig. 1 | Study hypotheses.
MEASURES
Speed of ART initiation
All participants in client interviews were asked how 
long it had been since they first learned they were 
HIV-positive, if they were currently on ART, and 
if so, the length of time they had been on ART. 
Responses were recorded in weeks, months, and 
years. For the present study, since we could not tell 
precisely when a client was truly first infected with 
HIV, we assumed that the reported date of first HIV-
positive test was the date of infection, but we sus-
pect that clients were concurrently diagnosed with 
HIV and AIDS. The literature suggests that roughly 
15–43% of HIV-positive people in low-income coun-
tries present for care with advanced stage (Stage 
3) disease or CD4 count at or below 350 cells per
cubic millimeter [24, 25]. As of September 2015,
the WHO recommends treatment initiation as soon
as one tests HIV-positive regardless of CD4 count,
but initiation within 30  days is considered to be
on time [25]. Prior to 2016, stage of disease, CD4
count, and HIV viral load were used in Ethiopia to
determine ART initiation [26]. More recently, the
Ethiopian Federal Ministry of Health adopted “Test
and Start,” recommended by PEPFAR guidelines,
which requires ART initiation for all clients who test
HIV-positive, regardless of stage of disease at diag-
nosis [13, 26].
To generate a measure of speed of ART initiation, 
we calculated the difference (in days) between the 
time participants first knew they were HIV-positive 
and first use of ART. Based on WHO’s definition 
of speed of ART initiation and clinical staging of 
HIV as described by US government’s Federal 
guidelines, speed of ART initiation was divided into 
five ordinal categories for analysis: “(1) Less than 
31  days,” “(2) 31–180  days,” “(3) 181–365  days,” 
“(4) 366–3,650 days,” and “(5) More than 10 years” 
[25, 27].  We coded speed of ART initiation such 
that lower categories indicated quicker initiation.
ART adherence
Adherence was measured as a continuous latent vari-
able. Clients were asked six questions from a stand-
ardized scale, known as the Simplified Medication 
Adherence Questionnaire (SMAQ) (Appendix 2). 
In the modeling, the latent variable is estimated 
using confirmatory factor analysis (CFA). We used 
multiple-group CFA with structural equation mod-
eling (SEM) to assess measurement invariance for 
latent adherence, and to develop the measurement 
model for adherence. SEM is an appropriate ana-
lytical methodology for assessing latent outcomes, 
such as adherence [28]. Measurement invariance is 
a statistical approach that is used to assess whether 
respondents interpreted measures conceptually 
similarly across groups and time and whether par-
ticipation in an intervention altered the conceptual 
frame of reference against which a group responded 
to an indicator over time [29]. The goal of measure-
ment invariance is to ascertain the extent to which 
a standardized scale measures the same construct 
across groups and time-points [30]. Results of this 
analysis showed that adherence was invariant across 
groups and time; therefore, we concluded that ad-
herence scores could be compared across groups 
using the same measurement model. To compare 
levels of latent adherence between intervention 
and control groups at T1 and T2, we used group 
code analysis, which uses data from both groups in 
a single SEM model by indicating the groups with a 
dummy variable [31–33].
Network density
As reported by Thomas et al. [15, 16], Kirkos had 69 
and 101 referral ties and network densities of 0.115 
and 0.183 at T1 and T2, respectively. Similarly, 
Kolfe-Keranyo had 101 and 40 referral ties and net-
work densities of 0.155 and 0.067 at T1 and T2, 
respectively. We used the same binary variable for 
comparison of adherence to distinguish the densities 
of the two networks, where participants were coded 
as 1 for being in the higher density intervention 
network or 0 for being in the lower density control 
network. 
Control variables
Control variables included client age (years), marital 
status (binary), satisfaction (categorical), education 
(categorical), and a wealth index (continuous), which 
was used as a proxy for income (Appendices 3 and 
4). We assessed the associations between control vari-
ables and outcomes in secondary analyses.
Analysis
Analyses were performed on four comparison
groups—both intervention and control networks at 
T1 and T2. To test our three hypotheses, we used 
mean- and variance-adjusted weighted least squares 
estimation, which is robust and appropriate for 
modeling ordinal and categorical data, as well as 
for multiple groups [34, 35]. The coefficients pro-
duced depend on the type of the outcome data. In 
this case, the probit estimates are used to calculate 
the probability that a woman with particular attrib-
utes falls into a specific category of speed of ART 
initiation [34]. Linear regression estimates are pro-
duced for continuous latent ART adherence. First, 
the invariant SMAQ permitted group comparisons 
of effects of control variables on latent adherence. 
Therefore, we ran multiple groups SEM for the 
whole data set with four study groups (control and 
intervention groups at T1 and T2—SEM Model 1). 
Secondly, to compare the levels of adherence and 
the effect of being in the intervention site on speed 
of ART initiation and adherence, we ran a com-
parison SEM for T1 and T2 separately and included 
being in the intervention as a binary variable (SEM 
Model 2). All the control variables in SEM Model 
1 were included in SEM Model 2 to check for con-
sistency of results. Finally, we calculated the dif-
ferences in average speed of ART initiation at T1 
and T2 in days to compare differences between 
networks. Key variables included: network density 
(intervention/control), time (T1/T2) interaction be-
tween networks and time. We used comparative fit 
index (CFI) >0.90, the Tucker Lewis Index (TLI) 
>.90 and root mean square error of approximation 
(RMSEA) <0.05 to assess model fit [36]. We report 
client statistics for the control variables and outcome 
variables, model fit indices, effect sizes, p-values, and 
the resulting SEM models. Correlation matrices for 
the variables are provided in Appendix 5. We used 
MPlus 7 to conduct data analysis [34].
RESULTS
Client characteristics
This study consisted of 926 female clients who were 
18–45  years of age and were receiving HIV treat-
ment and treatment support services from 51 service 
providers in two referral networks. The median age 
was 34 (range 18–45). Only one-third of the partic-
ipants lived with their sexual partner, of whom 2% 
were not married to them. Nearly one-quarter of 
all participants had no formal education, and only 
15% had post-primary education. Of the 80% who 
reported their weekly income, the average income 
was 2011 US$4 (range US$ 0–72) (Table 1). Based 
on individual frequencies for the six questions in 
SMAQ, self-reported adherence ranged from 60% to 
95% in both networks (Table 2). 
Model fit indices
All estimated models had good fit based on the 
root mean square error of approximation, Tucker 
Lewis Index, and comparative fit indices. The mul-
tiple groups SEM and comparison SEMs for T1 and 
T2 had RMSEA <0.6, CFI >0.95, and TLI >0.95 
(Table 3).
Speed of ART initiation and adherence
Our hypotheses tests were conducted using SEM 
Model 2 (Figs. 1 and 2 and Table 4). For the ordinal 
speed of ART initiation, the sign of the coefficient 
indicates the direction of the effect of the variable. 
A  positive coefficient indicates higher likelihood, 
versus lower for a negative coefficient, of quicker 
Table 1 | Demographic characteristics of 926 HIV-positive women who participated in the studya
Variable
Kolfe-Keranyo 
(control) T1
Kirkos (interven-
tion) T1
Kolfe-Keranyo 
(control) T2
Kirkos (interven-
tion) T2
Age (SD) 32 (6) 34 (6) 34 (5) 34 (6)
Education, %
(1) No school 33 16 29 17
(2) Adult education 5 5 7 8
(3) Primary (1–4 grades) 17 20 22 17
(4) Primary (5–8 grades) 34 39 29 40
(5) Secondary (9–10 grades) 6 13 11 17
(6) Preparatory (11–12 grades) 5 6 1 2
(7) Technical/vocational certificate 0 0.5 0 0
(8) University degree/associate degree 0.5 0.5 0 0
Marital status, %
(1) Married 40 26 33 31
(2) Not Married 60 74 67 69
Wealth index (SD) −1.5 (0.9) −1.1 (1.0) 0.6 (1.2) 1.4 (1.2)
Income per week in US$ (SD) 3 (7) 4 (7) 5 (6) 6 (6)
Speed of ART initiation, %
(1) <31 days 36 44 30 38
(2) 31–180 days 6 4 11 8
(3) 181–365 days 19 20 9 16
(4) 366–3,650 days 38 31 43 35
(5) >10 years 0.5 0.5 7 3
Satisfaction with HIV/AIDS care and support, %
(4) Very satisfied 59 65 52 49
(3) Somewhat satisfied 23 26 42 44
(2) Somewhat unsatisfied 15 6 4 4
(1) Unsatisfied 3 3 2 3
N 192 210 256 268
aExchange rate: 2011 US$ 1 = Ethiopian Birr 17.2836 (Source: National Bank of Ethiopia).
speed of ART initiation. For hypothesis 1, increased 
network density was associated with higher likeli-
hood of quicker speed of ART initiation (p < .05) 
(Table 4). Comparisons of speed of ART initiation 
revealed that on average a client in the interven-
tion network was initiated on ART 70 days earlier 
compared with their counterpart in the control at 
T2. However, the intervention network had quicker 
ART initiation even at T1 than control. Taking 
the difference at T1 into account, there was a net 
average effect of 15 days quicker ART initiation in 
the intervention network compared with control at 
T2 (Table 5). For hypothesis 2, our findings showed 
that speed of ART initiation predicted ART adher-
ence. A unit increase in speed of ART initiation was 
associated with an increase of 0.5 units of latent ad-
herence to ART (p < .05). Although we found no evi-
dence of direct association between network density 
and adherence, our results in hypotheses 1 and 2 
suggested a possible indirect association, but the test 
found no significant evidence for our third hypoth-
esis (p = .07) (Table 4, Figs. 1 and 2).
Our findings from SEM Model 1 showed that sat-
isfaction with care significantly predicted adherence 
Table 2 | Patient responses to the six-item adherence questionnaire (SMAQ) at baseline (T1) and follow-up (T2) in the intervention and 
control networks
Question 
T1 Responses to adherence 
questions (%)
T2 Responses to adherence 
questions (%)
Kolfe-Keranyo (control) 
n = 192
Kirkos (intervention) 
n = 209
Kolfe-Keranyo (control) 
n = 256
Kirkos (intervention) 
n = 265
1. Do you ever forget to 
take your medicine?
Yes 60 (31)  
No 132 (69)
Yes 76 (36)  
No 133 (64)
Yes 66 (26)  
No 190 (74)
Yes 77 (29)  
No 188 (71)
2. Are you careless at 
times about taking your 
medicine?
Yes 23 (12)  
No 169 (88)
Yes 31 (15)  
No 178 (85)
Yes 21 (8)  
No 233 (92)
Yes 30 (11)  
No 235 (89)
3. Sometimes if you feel 
worse, do you stop 
taking your medicines?
Yes 14 (7)  
No 178 (93)
Yes 19 (9)  
No 190 (91)
Yes 21 (8)  
No 233 (92)
Yes 24 (9)  
No 241 (91)
4. Thinking about the last 
week. How often have 
you not taken your 
medicine?
Never 162 (84) 1–2 
times 22 (11) 3–5 
times 6 (3) >5 times 
2 (1)
Never 169 (81) 1–2 
times 33 (16) 3–5 
times 7 (3) >5 times 
0 (0)
Never 222 (87) 1–2 
times 27 (11) 3–5 
times 5 (2) >5 times 
2 (1)
Never 223 (84) 1–2 
times 33 (12) 3–5 
times 7 (3) >5 times 
2 (1)
5. Did you not take any of 
your medicine over the 
past weekend?
Yes 9 (5)  
No 178 (95)
Yes 15 (7)  
No 194 (93)
Yes 13 (5)  
No 235 (95)
Yes 11 (5)  
No 254 (95)
6. Over the past 
3 months, how many 
days have you not 
taken any medicine 
at all?
≤2 days 183 (95) 
>2 days 9 (5)
≤2 days 189 (90) 
>2 days 20 (10)
≤2 days 227 (89) 
>2 days 28 (11)
≤2 days 244 (92) 
>2 days 21 (8)
Table 3 | Model fit indices for multiple groups SEM (T1 and T2 control and intervention) and control and intervention groups comparison 
SEM at T1 and T2 
Model fit indices
Estimates for SEM Model 1 
(T1 and T2 control and  
intervention groups)
Estimates for SEM 
Model 2 at T1
Estimates for SEM 
Model 2 at T2
Chi-square test of model fit
Value 188.13 56.27 63.28
Degrees of Freedom 144 34 34
p-value .01 .01 .00
RMSEA (Root Mean Square Error Of 
Approximation)
Estimate 0.04 0.04 0.04
90% C.I. 0.02–0.05 0.02–0.06 0.03–0.06
Probability RMSEA ≤ .05 .95 .79 .83
CFI/TLI 0.988/0.985 0.96/0.94 0.989/0.984
WRMR (Weighted Root Mean Square 
Residual)
1.65 0.86 0.83
in intervention network at T1 and T2, with a total 
effect of 0.6 and one-point increases, respectively (p 
< .05). Married women in the control network at T2 
were more likely to be initiated on ART later than 
their unmarried counterparts in the same network (p 
< .05) (Fig. 3 and Table 6). All our findings on asso-
ciations between dependent variables and control 
variables for both SEM Model 1 and SEM Model 2 
were all consistent.
DISCUSSION
Our analysis indicates that participants in the interven-
tion network were more likely to be initiated on ART 
quicker than their counterparts in the control network 
after the intervention, and in turn, this was associated 
with greater adherence to ART. Previous findings by 
Thomas et al. [15, 16] also showed that the interven-
tion was associated with an increase in referral ties, re-
duction in unmet social service needs, and increased 
satisfaction. The number of NGOs increased from 5 
to 14 and there were four FBOs in Kirkos, compared 
with a decrease from eight to five NGOs and only one 
FBO in Kolfe-Keranyo at T2 compared with T1. In 
addition, 16 providers in Kirkos compared with seven 
in Kolfe-Keranyo offered home-based care to people 
living with HIV/AIDS. The increased referral network 
density (referral ties) that was found in the interven-
tion site, together with increased number of providers 
there, may have resulted in increased access to and 
speed of ART initiation. 
Although ART speed slowed in both intervention 
and control sites, we found a 15-day difference in 
Table 4 | Estimates of effects of the intervention on speed of ART initiation and adherence at baseline (T1) and follow-up (T2) in Kolfe-
Keranyo and Kirkos—SEM Model 2
Outcome variable
Kolfe-Keranyo (control) compared with  
Kirkos (intervention) at T1
Kolfe-Keranyo (control) compared with  
Kirkos (intervention) at T2
Estimate p-value Estimate p-value
1. Effect of intervention on speed of 
ART initiation
−0.19 .11 −0.31 .01*
2. Effect of intervention on ART 
adherence
−0.41 .10 −0.36 .32
3. Effect of speed of ART initiation on 
ART adherence 
−0.10 .42 −0.46 .02*
*p < 0.05.
Table 5 | Comparison of unadjusted average number of days of speed of ART initiation between baseline (T1) and follow-up (T2) in Kolfe-
Keranyo and Kirkos
Time point Kolfe-Keranyo (control) Kirkos (intervention) Difference in days
T1 582 527 55
T2 687 617 70
Time × Group (% difference from T1) 105 (18%) 90 (17%) 15 
Fig. 2 | SEM model 2 at T2 with estimates of effect sizes and standard errors.
ART initiation favoring the intervention site. This 
finding could be attributed to sampling or the inter-
vention. It could be that the two networks were not 
fully comparable at baseline due to client demo-
graphic and organizational differences, but our find-
ings show that only the wealth index was higher in 
Kirkos. However, access to ART is influenced by a 
variety of factors [37]. Evidence suggests a 15-day 
quicker ART initiation speed has some clinical 
benefit for clients with more advanced HIV infec-
tion who are likely to develop life-threatening op-
portunistic infections [25]. In addition, there is some 
public health benefit for those with higher viral 
loads and who are sexually active [25]. Cohen et al. 
[38] reported the benefits of early ART initiation in
detail.
According to the WHO’s adherence model, ad-
herence requires multi-focal interventions that 
address health system-related, disease-related, treat-
ment-related factors and client determinants in 
an integrated manner, and increased and quicker 
access to ART alone were insufficient to control 
chronic conditions associated with HIV/AIDS [39]. 
In this sense, the increased access to ART and other 
HIV/AIDS services, which were associated with 
higher network density at the intervention site, may 
have been insufficient to significantly improve ad-
herence. According to the WHO, the ability of 
clinics and pharmacies to share information on cli-
ents’ behavior regarding prescription refills has the 
potential to improve adherence [39]. Although the 
intervention did not significantly improve adher-
ence directly, our finding shows that the intervention 
site, which had higher network density and a higher 
rate of information exchange, also reported some 
increased adherence. In addition, study follow-up 
Fig. 3 | SEM model 1 at T1 with estimates of effect sizes and standard errors for the control group. Table 4 contains effect size and 
standard error estimates of this model for all comparison groups.
Table 6 | Estimates of effects of control variables on speed of ART initiation and ART adherence—SEM Model 1 at baseline (T1) and follow-up 
(T2) in Kolfe-Keranyo and Kirkos
Speed of ART  
initiation on: 
Kolfe-Keranyo (control) 
at T1
Kirkos (intervention) 
at T1
Kolfe-Keranyo (control) 
at T2
Kirkos (intervention) 
at T2
Estimate p-value Estimate p-value Estimate p-value Estimate p-value
Age −0.02 .28 −0.01 .59 −0.02 .10 −0.02 .21
Education 0.08 .14 −0.06 .32 0.04 .51 0.09 .11
Married 0.45 .01* 0.02 .91 0.45 .00** 0.01 .93
Wealth index 0.18 .10 −0.02 .79 −0.07 .27 0.10 .08
Adherence on:
Age 0.02 .62 0.01 .85 0.07 .18 0.01 .89
Education −0.13 .27 −0.18 .18 −0.17 .37 −0.24 .23
Married 0.05 .89 0.72 .08 0.25 .68 0.66 .23
Wealth index −0.11 .67 −0.28 .11 0.35 .18 −0.02 .94
Speed of ART 
initiation
0.05 .79 −0.25 .19 −0.33 .25 −0.66 .03*
Satisfaction 0.16 .47 0.59 .02* 0.65 .12 0.98 .01*
N 191 209 252 266
*p<0.05; **p<0.01.
time of 18 months may have been too short for the 
time required for adherence to measurably improve. 
Interestingly, we found that married clients in 
the control site at T2 were initiated on ART later 
than unmarried clients in the same network. It is 
possible that married clients were less likely to 
seek care earlier due to stigma and discrimination 
associated with being HIV-positive or fear of di-
vorce or separation from spouses. Abaynew et al. 
[24] found that people who: lived with their fam-
ilies, had lived more than 2  years with a steady
partner, had not disclosed their HIV status and
perceived HIV stigma to be high, presented late
for HIV treatment. For similar reasons, they may
have been less likely to disclose their HIV status
to their spouses, even if they had tested and knew
they were HIV-positive. This finding may also be
due to the control site being more rural compared
with the intervention site. People in more rural
settings are more likely to live with families than
those in more urban ones. Anonymity in more
urbanized settings may also be associated with
less perceived stigma and promote early testing
and treatment seeking behavior.
Our findings also showed that an increase in sat-
isfaction with care was associated with increased ad-
herence. Roberts [40] found client satisfaction with 
care to be positively associated with HIV treatment 
adherence and concluded that strengthening rela-
tionships between clients and care providers should 
be a priority. Other studies have also demonstrated 
that satisfaction is an important factor for uptake, ad-
herence, and retention in treatment and that unsatis-
fied clients are likely to discontinue seeking care or 
to change providers [40–42].
Limitations of our study should be noted. One 
limitation is the potential for social desirability re-
sponse bias, which may be exacerbated in studies 
where interview questions are repeated. However, 
the cross-sectional design of the parent study mit-
igated this tendency. We also did not observe sig-
nificant changes in adherence across time in either 
group. Future studies should explore this associ-
ation using behavioral measures of adherence to 
avoid false reporting, which could strengthen the 
opportunity to establish an association between net-
work density and adherence. Future studies should 
also explore the association between satisfaction at 
patient-provider level and network density, and its 
effect on adherence. There is also a chance that cli-
ents misreported time of HIV diagnosis. This could 
have occurred if clients thought that reporting longer 
waiting time would be associated with quicker ART 
initiation, or if they forgot, which would be more 
likely if standard clinical procedures, including dis-
ease stage, CD4 count, and HIV viral load tests, 
were not followed. Integration of HIV care and full 
implementation of the “Test and Start” policy are 
likely to solve this issue.
CONCLUSION
The UNAIDS FastTrack Initiative is a framework 
that describes a roadmap for actions required to 
achieve the 90-90-90 and 95-95-95 treatment cas-
cades by 2020 and 2030, respectively [9, 10]. It 
is a scale-up initiative for ART that calls for rapid 
interventions: to increase value for money and ef-
ficient use of limited funds and resources, that are 
affordable to local governments, and that lead to 
increased community-based service delivery that 
brings services closer to the people who need them 
to improve service uptake [9, 10]. Our findings sug-
gest that the rapid, affordable, and non-complex 
referral network strengthening intervention, which 
was assessed in this study, may be one such initia-
tive. It was associated with an enhanced speed of 
ART initiation, which significantly and positively 
predicted adherence. Our findings are significant 
because Thomas et al. [15, 16] also found that the 
intervention network experienced increased net-
work ties and a decline in unmet client service needs. 
Adherence to ART is required for viral suppression. 
According to the UNAIDS, achievement of the 
third target requires sustained use of HIV treatment 
and ongoing virological monitoring to verify treat-
ment success and to intervene to support adherence 
and re-engage those who drop out of treatment [9]. 
This intervention has promise in contributing to the 
FastTrack Initiative because it is easily replicable in 
low-resource settings, such as the sub-Saharan Africa 
where the burden of HIV/AIDS is highest. 
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Appendix 1: Details of the methodology of parent study 
by MEASURE Evaluation researchers 
Data are from a quasi-experimental referral net-
work study conducted by MEASURE Evaluation. 
Kirkos was the site of an intervention aimed at 
improving ties among providers. Providers were 
identified using snowball sampling, beginning with 
well-known service providers as the seeds. All ser-
vice providers that offered, and could refer clients 
to one another for, HIV care and treatment sup-
port and family planning services to HIV-positive 
women of ages 18–49 were included. Saturation 
was reached when nominated organizational rep-
resentatives, who were also the interviewees for the 
study, named service providers that had already 
been named by others. Ultimately, 25 providers 
in Kirkos and 26 in Kolfe-Keranyo were included 
in the study. The data included provider charac-
teristics and linkages among providers. To ob-
tain referral network data, T1 (baseline) and T2 
(follow-up) interviews were conducted with nom-
inated key informants in each provider organiza-
tion about HIV services and the nature and types 
of referrals offered, provider characteristics, collab-
orations, joint programs, and linkages with other 
providers. 
Intervention
A referral network strengthening intervention was 
implemented in Kirkos where 21 of the 25 provid-
ers were represented in at least one of the meet-
ings. Kirkos was selected for the intervention after 
T1 results showed lower network density there 
compared with Kolfe-Keranyo. The intervention 
consisted of a series of three 2-day educational 
meetings held 2  months apart at different times 
after T1 data collection. During the meetings, par-
ticipants learned about strategies for client referral, 
collaboration, joint programming, and partner-
ships. They also learned about services offered by 
other facilities in the network. Service directories, 
listing contact information and services offered, 
were developed and shared, with each participat-
ing provider receiving at least one directory. No 
intervention was implemented in Kolfe-Keranyo, 
the control network.
Characteristics of service providers
Service providers in the two networks were owned 
and operated by the Ethiopian government or 
various types of non-governmental bodies. The 
government owned and operated 10 out of the 
51 service providers, whereas non-governmental 
organizations (NGOs), faith-based providers (FBOs) 
or private individuals owned and operated the re-
mainder. Kirkos had significantly fewer (three) gov-
ernment owned and operated providers compared 
with Kolfe-Keranyo, which had seven. There was 
a significant increase in the number of providers 
self-identifying as NGOs in Kirkos from five at T1 to 
14 at T2. Conversely, Kolfe-Keranyo experienced a 
reduction in the number of NGOs from eight at T1 
to five at T2. Providers in both networks reported 
significant increases in their budgets at T2 compared 
with T1, Kirkos had a total budget of US$685,535 
and US$ 1,910,340, whereas Kolfe-Keranyo had 
US$583,171 and US$ 5,510,505 at T1 and T2, re-
spectively. Kolfe-Keranyo had more staff at both 
time-points compared with Kirkos.
Appendix 2: Measurement of ART adherence
Patients were asked six questions from a standard-
ized scale, known as the Simplified Medication 
Adherence Questionnaire (SMAQ): 
1. Do you ever forget to take your medicine?
2. Are you careless at times about taking your medicine?
3. Sometimes if you feel worse, do you stop taking your
medicines?
4. Thinking about the last week, how often have you not
taken your medicine?
5. Did you not take any of your medicine over the past
weekend?
6. Over the past three months, how many days have you
not taken any medicine at all?
A “yes” response to questions 1, 2, 3, and 5 con-
stituted non-adherence, whereas values >0 for 
question 4 and values >2 for question 6 consti-
tuted non-adherence. For analysis, the values were 
flipped such that “no,” 0 days and ≤2 days consti-
tuted adherence for questions 1, 2, 3 and 5, 4, and 
6, respectively.
Initial assessment of correlations between the six 
indicators of adherence demonstrated that the ques-
tion “did you not take any of your medicine over the 
last weekend” was weakly and negatively correlated 
(−0.09), with “if at times you feel worse, do you stop 
taking your medicine” in the T1 intervention group, 
and was, therefore, excluded from the rest of the 
analysis.
Appendix 3: Satisfaction with HIV/AIDS Care
Patient satisfaction with HIV care is an important 
indicator for QOL and health outcomes among 
HIV-positive people. The literature suggests that 
patients who are satisfied with their HIV care 
are more likely to be retained in care and reten-
tion in care is one of the goals of the UNAIDS 
Fast-Track 90-90-90 Initiative. We hypothesized 
that adherence and satisfaction with HIV care 
Appendix 5: Correlation matrices
1. Correlation matrix for T1 control group—for SEM Model 1
Age Education Married
Wealth 
index Adhere1 Adhere2 Adhere3 Adhere4 Adhere5
Speed 
of ART 
initiation Satisfaction
Age 1.00
Education 0.02 1.00
Married 0.13 0.10 1.00
Wealth index 0.12 0.31 0.08 1.00
Adhere1 0.05 −0.04 0.02 −0.05 1.00
Adhere2 −0.11 −0.25 −0.21 −0.05 0.22 1.00
Adhere3 −0.12 −0.38 −0.12 −0.13 0.43 0.63 1.00
Adhere4 0.14 −0.04 0.10 −0.18 0.73 0.06 0.35 1.00
Adhere5 0.06 −0.11 0.01 0.06 0.75 0.32 0.51 0.70 1.00
Speed of ART 
initiation
−0.04 0.18 0.21 0.20 0.02 −0.09 0.05 −0.06 −0.02 1.00
Satisfaction −0.04 −0.07 −0.03 −0.16 −0.07 0.18 0.23 0.12 0.07 −0.07 1.00
have a concomitant association. Thus, patients 
with higher adherence scores were more likely to 
have better health outcomes, including less dis-
ease severity, which is likely to lead to higher sat-
isfaction. We also hypothesized that speed of ART 
initiation indirectly affects satisfaction, through 
adherence. Thus, patients with higher adherence 
scores were more likely to be more satisfied with 
HIV care. Moreover, patients with higher satis-
faction scores are more likely to follow providers’ 
instructions and, therefore, report higher satisfac-
tion. However, we did not test the foregoing asso-
ciation due to lack of an appropriate instrumental 
variable. More adherent patients are more likely 
to have improved functional status, which may im-
prove their satisfaction.
Patients responded to four questions about satisfaction: 
1. Do you feel that your health needs are being met?
Would you say that: 1. All your health needs are being
met; 2. Most are being met; 3. Some are being met, or
4. Very few or none are being met?
2. Overall, how satisfied have you been with the care ser-
vices you receive for your HIV disease? Would you say: 
1. Very satisfied; 2. Somewhat satisfied; 3. Somewhat
unsatisfied; or 4. Unsatisfied?
3. Overall, how satisfied have you been with family
planning services you receive? Would you say: 1. Very
satisfied; 2. Somewhat satisfied; 3. Somewhat unsatis-
fied; or 4. Unsatisfied?
4. Which HIV or FP services are you particularly very
satisfied/unsatisfied with? Responses for this question
were free-entry and open-ended format.
We recoded the values from 1–4 to 4–1 to make 
the scale intuitive such that the highest satisfaction 
level was coded with the highest number in the 
scale. These questions were asked of all participants 
and may have been influenced by satisfaction lev-
els of various types of health services needed and 
received, for example, family planning services, not 
just HIV/AIDS care and support services. We could 
not disentangle the components of the responses for 
the three questions, which were non-specific to HIV/
AIDS care and support. Therefore, we only used 
the second question on the list above to measure 
satisfaction. 
Appendix 4: Use of principal components analysis to 
generate household wealth index (as described by 
Filmer D and Pritchett LH. 2001)
Due to the limitations of the data on household in-
come, we used principal components analysis to derive 
a linear wealth index from 12 observable household 
asset indicators. Principal components analysis (PCA) 
is a data reduction process that condenses many 
observed variables into a single measure. In PCA, 
components are uncorrelated linear combinations of 
factors (observed variables) that maximize the total 
variance. Other researchers have used this method-
ology to estimate linear wealth indices when income 
or expenditure data were not available for inclusion in 
statistical analyses. Compared with income, this index 
better reflected a household’s long-term economic 
status and overall economic well-being. To generate 
the wealth index, we included the following household 
assets, all were measured as categorical and each cat-
egory was converted to binary format: 
1. Material used to make the floor, walls and roof of the
main house,
2. Main type of toilet,
3. Main source of drinking water,
4. Main source of energy for cooking, and
5. Whether the household owned a car, bicycle, refriger-
ator, television set, mobile phone, or a radio.
The histogram of the first principal component, 
while not normally distributed, depicts a better dis-
tribution when compared with that of income. 
2. Correlation matrix for T1 intervention group—for SEM Model 1
Age Education Married
Wealth 
index Adhere1 Adhere2 Adhere3 Adhere4 Adhere5
Speed 
of ART 
initiation Satisfaction
Age 1.00
Education −0.03 1.00
Married 0.10 0.07 1.00
Wealth index 0.00 0.26 −0.03 1.00
Adhere1 −0.08 −0.15 0.09 −0.15 1.00
Adhere2 0.09 −0.07 −0.01 −0.23 0.30 1.00
Adhere3 −0.09 0.11 0.00 0.11 0.44 0.24 1.00
Adhere4 0.02 −0.19 0.17 −0.16 0.80 0.21 0.31 1.00
Adhere5 0.15 −0.08 0.18 −0.06 0.71 0.55 0.51 0.73 1.00
Speed of ART 
initiation
−0.04 −0.09 0.00 −0.06 −0.18 −0.27 −0.21 0.15 −0.04 1.00
Satisfaction −0.05 0.01 −0.04 0.14 0.14 −0.16 0.28 0.16 0.17 −0.09 1.00
3. Correlation matrix for T2 control group—for SEM Model 1
Age Education Married
Wealth 
index Adhere1 Adhere2 Adhere3 Adhere4 Adhere5
Speed 
of ART 
initiation Satisfaction
Age 1.00
Education 0.04 1.00
Married 0.21 0.07 1.00
Wealth index 0.03 0.27 −0.04 1.00
Adhere1 0.13 0.00 −0.02 0.10 1.00
Adhere2 −0.03 −0.01 0.10 −0.01 0.55 1.00
Adhere3 0.29 −0.27 0.20 0.19 0.50 0.64 1.00
Adhere4 0.12 0.08 0.06 0.11 0.86 0.63 0.63 1.00
Adhere5 0.06 −0.04 −0.06 0.13 0.89 0.59 0.51 0.87 1.00
Speed of ART 
initiation
−0.05 0.03 0.18 −0.08 −0.06 −0.12 −0.16 −0.08 −0.09 1.00
Satisfaction −0.12 0.04 −0.02 0.01 0.06 0.09 0.05 0.23 0.07 −0.04 1.00
4. Correlation matrix for T2 intervention group—for SEM Model 1
Age Education Married
Wealth 
index Adhere1 Adhere2 Adhere3 Adhere4 Adhere5
Speed 
of ART 
initiation Satisfaction
Age 1.00
Education −0.03 1.00
Married 0.10 0.00 1.00
Wealth index 0.10 0.16 −0.10 1.00
Adhere1 0.03 −0.08 0.16 −0.06 1.00
Adhere2 0.08 −0.06 0.04 −0.13 0.46 1.00
Adhere3 0.08 −0.23 0.17 −0.09 0.62 0.68 1.00
Adhere4 −0.09 −0.11 0.04 −0.10 0.85 0.46 0.56 1.00
Adhere5 0.02 −0.15 0.02 0.00 0.95 0.42 0.63 0.87 1.00
Speed of ART 
initiation
−0.07 0.14 −0.02 0.12 −0.23 −0.22 −0.16 −0.20 −0.24 1.00
Satisfaction −0.09 0.01 0.00 −0.04 0.15 0.11 0.21 0.27 0.18 −0.08 1.00
5. Correlation matrix for control and intervention groups at T1—for SEM Model 2
Age Education Married
Wealth 
index Adhere1 Adhere2 Adhere3 Adhere4 Adhere5
Speed 
of ART 
initiation SatisfactionIntervention
Age 1.00
Education 0.03 1.00
Married 0.14 0.11 1.00
Wealth index 0.09 0.31 0.05 1.00
Adhere1 −0.03 −0.11 0.04 −0.12 1.00
Adhere2 −0.01 −0.16 −0.11 −0.17 0.27 1.00
Adhere3 −0.11 −0.12 −0.06 −0.01 0.44 0.43 1.00
Adhere4 0.06 −0.13 0.13 −0.18 0.77 0.16 0.33 1.00
Adhere5 0.08 −0.12 0.09 −0.06 0.72 0.47 0.51 0.72 1.00
Speed of 
ART 
initiation
−0.05 0.03 0.09 0.03 −0.09 −0.19 −0.10 0.06 −0.01 1.00
Satisfaction −0.02 −0.01 −0.02 0.02 0.03 0.01 0.25 0.13 0.11 −0.09 1.00
Intervention 0.17 0.18 0.14 0.23 −0.07 −0.08 −0.06 −0.07 −0.19 −0.09 0.10 1.00
6. Correlation matrix for control and intervention groups at T2—for SEM Model 2
Age Education Married
Wealth 
index Adhere1 Adhere2 Adhere3 Adhere4 Adhere5
Speed 
of ART 
initiation SatisfactionIntervention
Age 1.00
Education 0.01 1.00
Married 0.15 0.04 1.00
Wealth index 0.07 0.25 −0.06 1.00
Adhere1 0.08 −0.05 0.07 0.00 1.00
Adhere2 0.03 −0.05 0.07 −0.10 0.50 1.00
Adhere3 0.17 −0.25 0.19 0.02 0.56 0.66 1.00
Adhere4 0.01 −0.02 0.05 −0.02 0.85 0.54 0.59 1.00
Adhere5 0.04 −0.10 −0.02 0.06 0.92 0.50 0.57 0.87 1.00
Speed of 
ART 
initiation
−0.06 0.05 0.08 −0.03 −0.14 −0.16 −0.15 −0.13 −0.16 1.00
Satisfaction −0.11 0.02 −0.01 −0.03 0.11 0.11 0.14 0.25 0.13 −0.05 1.00
Intervention 0.03 0.17 0.03 0.34 −0.05 −0.09 −0.03 −0.06 −0.01 −0.14 −0.05 1.00
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